This mechanism aligns with the YAP-MDSC axis previously proposed by Wang et.al 24,50,54 in prostate cancer, pancreatic ductal adenocarcinoma and liver ischemia-reperfusion injury. Here, YAP1 is linked to prostate carcinoma.